Back Login for AI Analysis

    OLMA (STOCKS)

    Olema Pharmaceuticals, Inc. Common Stock

    $10.510000
    +0.070000 (+0.67%)
    Prev close: $10.440000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Sean P. Bohen
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $918.72M
    Employees
    117
    P/E (TTM)
    -4.96
    P/B (TTM)
    2.12
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Analyst Recommendations
    6
    Strong Buy
    10
    Buy
    2
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Jun 2026 (Q2)
    		 $-0.61 $-0.56 -0.0546 -9.83%
    Mar 2026 (Q1)
    		 $-0.52 $-0.54 +0.0194 +3.60%
    Dec 2025 (Q4)
    		 $-0.50 $-0.54 +0.0393 +7.29%
    Sep 2025 (Q3)
    		 $-0.49 $-0.49 +0.0033 +0.67%
    Financial Statements
    TTM (Jun 2026)
    Revenues $0.00
    Nonoperating Income/Loss $16.56M
    Operating Expenses $221.13M
    Research and Development $190.19M
    Other Operating Expenses $30.94M
    Operating Income/Loss -$221.13M
    Income/Loss From Continuing Operations After Tax -$204.57M
    Income/Loss From Continuing Operations Before Tax -$204.56M
    Net Income/Loss -$204.57M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$204.57M
    Net Income/Loss Available To Common Stockholders, Basic -$204.57M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$2.12
    Diluted Earnings Per Share -$2.12
    Basic Average Shares 190,816,653
    Diluted Average Shares 190,816,653
    Assets $486.58M
    Current Assets $469.88M
    Cash $461.10M
    Other Current Assets $8.78M
    Noncurrent Assets $16.70M
    Fixed Assets $382.00K
    Other Non-current Assets $16.32M
    Liabilities $56.01M
    Current Liabilities $53.01M
    Accounts Payable $1.67M
    Wages $655.00K
    Other Current Liabilities $50.69M
    Noncurrent Liabilities $3.00M
    Equity $430.56M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $430.56M
    Liabilities And Equity $486.58M
    Net Cash Flow From Operating Activities -$164.74M
    Net Cash Flow From Operating Activities, Continuing -$164.74M
    Net Cash Flow From Investing Activities -$99.54M
    Net Cash Flow From Investing Activities, Continuing -$99.54M
    Net Cash Flow From Financing Activities $260.40M
    Net Cash Flow From Financing Activities, Continuing $260.40M
    Net Cash Flow -$3.87M
    Net Cash Flow, Continuing -$3.87M
    Comprehensive Income/Loss -$205.83M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$205.83M
    Other Comprehensive Income/Loss -$106.68M